EP Patent

EP2322516A1 — Intermediates for the preparation of Macrocyclic inhibitors of hepatitis c virus

Assigned to Janssen Sciences Ireland ULC · Expires 2011-05-18 · 15y expired

What this patent protects

A process for the preparation of a compound of formula comprising the ring closure and dehydration of a compound of formula

USPTO Abstract

A process for the preparation of a compound of formula comprising the ring closure and dehydration of a compound of formula

Drugs covered by this patent

simeprevir-sodium (SIMEPREVIR SODIUM)

Patent Metadata

Patent number: EP2322516A1
Jurisdiction: EP
Classification: —
Expires: 2011-05-18
Drug substance claim: No
Drug product claim: No
Assignee: Janssen Sciences Ireland ULC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.